Management and grading of EGFR inhibitor-induced cutaneous toxicity
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Management and grading of EGFR inhibitor-induced cutaneous toxicity
Authors
Keywords
-
Journal
Future Oncology
Volume -, Issue -, Pages -
Publisher
Future Medicine Ltd
Online
2018-05-05
DOI
10.2217/fon-2018-0187
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EVITA—a double-blind, vehicle-controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity
- (2018) R -D Hofheinz et al. ANNALS OF ONCOLOGY
- Placebo-controlled phase II study of vitamin K3 cream for the treatment of cetuximab-induced rash
- (2017) Jesper Grau Eriksen et al. SUPPORTIVE CARE IN CANCER
- Efficacy of chemotherapy plus cetuximab according to metastatic site in KRAS wild-type metastatic colorectal cancer (mCRC): Analysis of CRYSTAL and OPUS studies.
- (2017) C. Kohne et al. JOURNAL OF CLINICAL ONCOLOGY
- NCCN Task Force Report: Management of Dermatologic and Other Toxicities Associated With EGFR Inhibition in Patients With Cancer
- (2017) Barbara Burtness et al. Journal of the National Comprehensive Cancer Network
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors
- (2016) R.-D. Hofheinz et al. ONCOLOGIST
- Current targeted therapies in the treatment of advanced colorectal cancer: a review
- (2016) Andrew Moriarity et al. Therapeutic Advances in Medical Oncology
- Randomized controlled trial on the skin toxicity of panitumumab in Japanese patients with metastatic colorectal cancer: HGCSG1001 study; J-STEPP
- (2015) Yoshimitsu Kobayashi et al. Future Oncology
- Anticipating and managing the cutaneous side effects of epidermal growth factor receptor inhibitors
- (2014) Rod Sinclair Asia-Pacific Journal of Clinical Oncology
- Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patients
- (2014) Tanusree Paul et al. EUROPEAN JOURNAL OF CANCER
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- The Epidermal Growth Factor Receptor Inhibitor-Related Skin Toxicity Index (EGFRISTI): A New Tool for Grading and Managing Skin Adverse Reactions to Epidermal Growth Factor Receptor Inhibitors
- (2014) Paolo Lisi et al. ONCOLOGY
- Targeted therapy in advanced metastatic colorectal cancer: Current concepts and perspectives
- (2014) Florian Hohla WORLD JOURNAL OF GASTROENTEROLOGY
- The effects of treatment on itch in atopic dermatitis
- (2013) Kevin B. Yarbrough et al. Dermatologic Therapy
- The development of a Functional Assessment of Cancer Therapy (FACT) questionnaire to assess dermatologic symptoms associated with epidermal growth factor receptor inhibitors (FACT-EGFRI-18)
- (2012) Lynne I. Wagner et al. SUPPORTIVE CARE IN CANCER
- Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm
- (2012) Z. Reguiai et al. SUPPORTIVE CARE IN CANCER
- Economic burden of dermatologic adverse drug reactions in the treatment of colorectal, non-small cell lung, and head and neck cancers with epidermal growth factor receptor inhibitors
- (2012) Saurabh Ray et al. JOURNAL OF MEDICAL ECONOMICS
- Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
- (2011) Mario E. Lacouture et al. SUPPORTIVE CARE IN CANCER
- Skin Toxicity Evaluation Protocol With Panitumumab (STEPP), a Phase II, Open-Label, Randomized Trial Evaluating the Impact of a Pre-Emptive Skin Treatment Regimen on Skin Toxicities and Quality of Life in Patients With Metastatic Colorectal Cancer
- (2010) Mario E. Lacouture et al. JOURNAL OF CLINICAL ONCOLOGY
- How well does the MESTT correlate with CTCAE scale for the grading of dermatological toxicities associated with oral tyrosine kinase inhibitors?
- (2010) Alexandre Chan et al. SUPPORTIVE CARE IN CANCER
- Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy
- (2009) R. E. Eilers et al. JNCI-Journal of the National Cancer Institute
- Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes
- (2008) Aminah Jatoi et al. CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started